Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer

NCT05815316 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT05815316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05815316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer
Lead sponsor
IRCCS San Raffaele
Phase
Phase 2
Overall status
Withdrawn
Start date
April 30, 2023
Completion date
April 29, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer